agenc also agre comment state unproven hypothesi overus antisept caus pseudomona overgrowth summari basi approv approv nda chlorhexidin glucon ref 1 cite skin flora studi indic axilla area gram neg micro organ continu isol even though chlorhexidin glucon shown gram neg effect comment cite fda divis anti infect drug product recognit health care use surgic scrub health care personnel handwash would problem pseudomona overgrowth hand area bodi like support growth pseudomona lack moistur defend triclosan comment contend ingredi bacteriostat elimin gram posit bacteria therefor would predispos gram neg overgrowth triclosan implic pseudomona contamin primarili effect gram posit bacteria limit vitro vivo activ gram neg bacteria activ pseudomona 43 fr 1210 1232 one report show triclosan effect gram neg micro organ effect serratia pseudomona ref 11 pseudomona serratia resist caus contamin overus antisept agenc agre comment quaternari ammonium compound triclosan implic pseudomona hospit infect frequent povidon iodin studi indic overus antimicrobi caus pseudomona speci may becom domin inher resist factor enabl surviv effect mani antibiot antisept ref 12 13 14 addit genu ubiquit found soil water multipli almost moist environ even trace organ materi ref 15 agenc believ data report provid specif evid repeat use health care antisept includ benzalkonium chlorid triclosan brought overgrowth gram neg bacteria particularli pseudomona agenc agre comment improp use failur hospit personnel use accord label indic nonasept techniqu dilut handl lack good qualiti control ensur steril item contact antisept steril distil water hose receptacl respons studi houang et al ref 3 show repeat vitro exposur seven gram neg micro organ includ p aeruginosa povidon iodin dilut result develop resist agenc note cdc previous recommend povidon iodin use intraven cathet procedur ref 2 howev one report cdc ref 16 describ pseudomona hospit infect caus intrins contamin povidon iodin contamin manufactur indic failur control microbiolog contamin complianc agenc regul govern current good manufactur practic finish pharmaceut 21 cfr part 211 prevent intrins contamin accordingli agenc conclud cautionari statement overus need profession label health care antisept drug product therefor previous propos caution 333 99 includ tent final monograph new inform indic need cautionari statement agenc consid appropri action time